Osilodrostat | List of Frontiers open access articles

Case Report

Published on 15 Sep 2025

Prolonged adrenal suppression after osilodrostat discontinuation in a patient with Cushing’s disease with eventual hypercortisolism relapse: Case Report and literature review

in Translational Medicine

Lukasz Dzialach
Wioleta Respondek
Anna Siejka
Przemyslaw Witek

Frontiers in Medicine

doi 10.3389/fmed.2025.1629387

2,885 views
1 citation

Original Research

Published on 23 Aug 2023

Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension

in Pituitary Endocrinology

Mônica Gadelha
Peter J. Snyder
Przemysław Witek
Marie Bex
Zhanna Belaya
Adina F. Turcu
Richard A. Feelders
Anthony P. Heaney
Michaela Paul
Alberto M. Pedroncelli

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1236465

10,136 views
38 citations

Original Research

Published on 18 Dec 2025

Case Report: Ectopic Cushing’s syndrome caused by a pancreatic neuroendocrine tumor managed through dual steroidogenesis inhibition and endoscopic ultrasound-guided ethanol ablation

in Neuroendocrine Science

Łukasz Krzystek
Karol P. Sagan
Elżbieta Andrysiak-Mamos
Szymon Retfiński
Karolina Buć
Wiktoria Marczak
Anna Brzeska
Martyna Patalong-Wójcik
Ewa Żochowska
Krzysztof Dąbkowski

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1700273

1,340 views
1 citation

Original Research

Published on 13 Jun 2022

Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study

in Pituitary Endocrinology

Mario Detomas
Barbara Altieri
Timo Deutschbein
Martin Fassnacht
Ulrich Dischinger

Frontiers in Endocrinology

doi 10.3389/fendo.2022.903545

10,805 views
36 citations

Systematic Review

Published on 17 Sep 2021

Effectiveness of Medical Treatment of Cushing’s Disease: A Systematic Review and Meta-Analysis

in Pituitary Endocrinology

Julia Simões Corrêa Galendi
Afonso Nogueira Simões Correa Neto
Michelle Demetres
Cesar Luiz Boguszewski
Vania dos Santos Nunes Nogueira

Frontiers in Endocrinology

doi 10.3389/fendo.2021.732240

14,302 views
31 citations

Original Research

Published on 07 Nov 2025

Clinical management of ectopic Cushing Syndrome in neuroendocrine neoplasms: a national survey

in Cancer Endocrinology

Alice Laffi
Antonio Prinzi
Carla Di Dato
Tiziana Feola
Margherita Medici
Annamaria Colao
Antongiulio Faggiano
Andrea Gerardo Antonio Lania

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1690837

1,588 views
1 citation

Articles

Prolonged adrenal suppression after osilodrostat discontinuation in a patient with Cushing’s disease with eventual hypercortisolism relapse: Case Report and literature review

Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension

Case Report: Ectopic Cushing’s syndrome caused by a pancreatic neuroendocrine tumor managed through dual steroidogenesis inhibition and endoscopic ultrasound-guided ethanol ablation

Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study

Effectiveness of Medical Treatment of Cushing’s Disease: A Systematic Review and Meta-Analysis

Clinical management of ectopic Cushing Syndrome in neuroendocrine neoplasms: a national survey